Cellaïon
0764.522.425 · rovalta.com · 23/09/2026
Cellaïon
Company — Voluntary dissolution - liquidation.
Overview
What does Cellaïon do?
Cellaïon is a Public limited company incorporated in 2021. Its main activity is: Other human health activities. Its registered office is in Mont-Saint-Guibert.
1435 Mont-Saint-Guibert · WallonieSee on map
Joint committees (1)
- 207
Trend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -25,2 k € | +99.4% | -4 M € | +38.9% | -6,6 M € | -8.4% | -6,1 M € | -147% | -2,5 M € |
| EBITDA | -25,2 k € | +99.7% | -8,3 M € | +26.6% | -11,3 M € | -27.8% | -8,8 M € | -72.8% | -5,1 M € |
| Operating result | -25,2 k € | +99.7% | -7,7 M € | +41.5% | -13,1 M € | -42.3% | -9,2 M € | -64.5% | -5,6 M € |
| Net result | -15,7 k € | +99.8% | -7,7 M € | +41.8% | -13,2 M € | -40.9% | -9,4 M € | -66.4% | -5,6 M € |
| Balance sheet | |||||||||
| Equity | -13,9 M € | -0.1% | -13,8 M € | -125% | -6,1 M € | -686% | 1 M € | +119% | -5,6 M € |
| Total assets | 2,3 M € | -2.5% | 2,3 M € | -68.8% | 7,5 M € | -39.5% | 12,4 M € | +129% | 5,4 M € |
| Cash | 1,4 M € | +11.7% | 1,2 M € | -56.7% | 2,9 M € | -65.2% | 8,3 M € | +2055% | 385,1 k € |
| Debts | 15,1 M € | -0.3% | 15,1 M € | +30.7% | 11,6 M € | +6.3% | 10,9 M € | +3.2% | 10,5 M € |
| Other | |||||||||
| Workforce | 0,0 ETP | -100% | 15,5 ETP | -38.5% | 25,2 ETP | +6.8% | 23,6 ETP | -11.9% | 26,8 ETP |
Board of directors
Seen on filing of 31/12/2025 · 1 active · 32 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
Ascend Performance Materials● Active | 0810.113.316 |
| 1012.379.397 | |
AUDANE INVEST● Active | 0816.921.429 |
BiocSol● Active | 1003.683.546 |
CEDRIC CLAERHOUDT● Active | 0477.799.927 |
| 0859.906.087 | |
Cronos Sud● Active | 1014.190.824 |
DE SMET AGRO● Active | 0402.951.757 |
| 0438.987.752 | |
FLEXSO BRUSSELS● Active | 0898.889.892 |
Keiro● Active | 0681.490.821 |
NOVADIP BIOSCIENCES● Active | 0535.575.602 |
PARLYM BELGIUM● Active | 1028.144.372 |
PARSMET MANAGEMENT● Active | 1025.167.858 |
PROMETHERA BIOSCIENCES● Bankrupt | 0809.788.365 |
TFP IMMO● Active | 1032.940.330 |
The Akkermansia Company● Active | 0664.529.083 |
THE TORREFACTORY PROJECT● Active | 0679.686.720 |
Tools4Patient● Active | 0534.842.954 |
VAT Group Ascend● Active | 1002.911.308 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 02/03/2021 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 10 months |
| Filing date | 25/07/2026 | 18/07/2025 | 27/06/2024 | 09/06/2023 | 24/06/2022 |
| General meeting | 30/06/2026 | 16/07/2025 | 31/05/2024 | 10/05/2023 | 02/06/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
5 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/06/2026 | 25/07/2026 | French | |
| Abridged model | 31/12/2024 | 16/07/2025 | 18/07/2025 | French | |
| Abridged model | 31/12/2023 | 31/05/2024 | 27/06/2024 | French | |
| Abridged model | 31/12/2022 | 10/05/2023 | 09/06/2023 | French | |
| Abridged model | 31/12/2021 | 02/06/2022 | 24/06/2022 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 32 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates15/07/2024RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...) - DEMISSIONS, NOMINATIONS
- Mandates02/04/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DEMISSIONS, NOMINATIONS
- Other25/01/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates08/12/2023DEMISSIONS, NOMINATIONS
- Mandates09/10/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DEMISSIONS, NOMINATIONS
- Capital / shares23/06/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Mandates02/02/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Mandates23/02/2022DEMISSIONS, NOMINATIONS
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-15,7 k €↑
- 2024Annual accounts 2024-7,7 M €↑
- 2023Annual accounts 2023-13,2 M €↓
- 2022Annual accounts 2022-9,4 M €↓
- 2021Annual accounts 2021-5,6 M €
- 02/03/2021IncorporationPublic limited company